A further two contracts worth a combined £111,000 were announced this morning by the Company, as the total revenue pipeline continues to build. These contracts with a new UK-based biopharmaceutical client have been won by the recently established Biometrics services division. The Physiomics team have delivered over 100 commercial projects for drug development clients, including but not limited to, Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics and Cancer Research UK.
The Biomet ....
